Peter Wostyn

Peter Wostyn, MD, works in the Department of Psychiatry, Psychiatrisch Centrum Sint-Amandus, Beernem, Belgium and is a co-founder of P&X Medical, a biotech company focused on the treatment of intracranial pressure, cerebrospinal fluid turnover and glymphatic flow in neurodegenerative disorders, with a primary focus on glaucoma.

Dr Wostyn developed the glymphatic dysfunction hypothesis which postulates that a dysfunction of the waste clearance system, called the glymphatic system, causes a build-up of toxins within the central nervous system, which precipitates at least some cases of chronic fatigue syndrome.

Notable studies

 * 2018, Can cerebrospinal fluid diversion be beneficial in the treatment of chronic fatigue syndrome?
 * 2018, The putative glymphatic signature of chronic fatigue syndrome: A new view on the disease pathogenesis and therapy - (Abstract)


 * 2019, Retinal nerve fiber layer thinning in chronic fatigue syndrome as a possible ocular biomarker of underlying glymphatic system dysfunction